ArticleInternational journal of immunopathology and pharmacology

A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.

Ahmet Kucuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.